These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19519426)

  • 1. Targeted delivery of anti-inflammatory agents to tumors.
    Coimbra M; Kuijpers SA; van Seters SP; Storm G; Schiffelers RM
    Curr Pharm Des; 2009; 15(16):1825-43. PubMed ID: 19519426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte adhesion: a suitable target for anti-inflammatory drugs.
    Mrowietz U; Boehncke WH
    Curr Pharm Des; 2006; 12(22):2825-31. PubMed ID: 16918413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting inflammatory mediators with ferulic acid, a dietary polyphenol, for the suppression of monosodium urate crystal-induced inflammation in rats.
    Doss HM; Dey C; Sudandiradoss C; Rasool MK
    Life Sci; 2016 Mar; 148():201-10. PubMed ID: 26851531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation.
    Coimbra M; Banciu M; Fens MH; de Smet L; Cabaj M; Metselaar JM; Storm G; Schiffelers RM
    J Control Release; 2010 Dec; 148(3):303-10. PubMed ID: 20869410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and potential inflammation targeted therapies in head and neck cancer.
    Wang F; Arun P; Friedman J; Chen Z; Van Waes C
    Curr Opin Pharmacol; 2009 Aug; 9(4):389-95. PubMed ID: 19570715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Chemical Society--234th National Meeting. Targeting inflammation. 19-23 August 2007, Boston, MA, USA.
    Dalziel C; Veryard C
    IDrugs; 2007 Oct; 10(10):674-5. PubMed ID: 17899478
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD.
    Morjaria JB; Malerba M; Polosa R
    Drug Discov Today; 2010 May; 15(9-10):396-405. PubMed ID: 20223295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timely lessons for target-based discovery of anti-inflammatory drugs.
    Szymkowski DE
    Drug Discov Today; 2005 Jan; 10(1):14-7. PubMed ID: 15676294
    [No Abstract]   [Full Text] [Related]  

  • 9. Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs.
    Serpe L; Canaparo R; Foglietta F; Zara GP
    Curr Pharm Des; 2013; 19(41):7219-36. PubMed ID: 23489201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1 as a target in inflammation.
    Ito Y; Kaneko N; Iwasaki T; Morikawa S; Kaneko K; Masumoto J
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):206-11. PubMed ID: 26333726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer and inflammation: implications for pharmacology and therapeutics.
    Balkwill F; Mantovani A
    Clin Pharmacol Ther; 2010 Apr; 87(4):401-6. PubMed ID: 20200512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity.
    Kluza E; Yeo SY; Schmid S; van der Schaft DW; Boekhoven RW; Schiffelers RM; Storm G; Strijkers GJ; Nicolay K
    J Control Release; 2011 Apr; 151(1):10-7. PubMed ID: 21130819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids as an adjunct to oncologic treatment in solid malignancies - Not an innocent bystander.
    Maurice-Dror C; Perets R; Bar-Sela G
    Crit Rev Oncol Hematol; 2018 Jun; 126():37-44. PubMed ID: 29759565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose titration of steroidal and non-steroidal topical anti-inflammatory agents.
    Sanen FJ; Van Scott E; Bayard S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):174-9. PubMed ID: 1100536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents.
    Urbanska AM; Zhang X; Prakash S
    Cell Biochem Biophys; 2015 Jul; 72(3):757-69. PubMed ID: 27352189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric delivery systems for dexamethasone.
    Urbańska J; Karewicz A; Nowakowska M
    Life Sci; 2014 Feb; 96(1-2):1-6. PubMed ID: 24373835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological and biotechnological strategies for drug delivery.
    Galdiero M; Caraglia M
    Curr Drug Metab; 2012 Jan; 13(1):2-3. PubMed ID: 22385533
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug delivery strategies in the therapy of inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Fischer D; Stallmach A
    Adv Drug Deliv Rev; 2014 May; 71():58-76. PubMed ID: 24157534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation.
    Anselmo AC; Gilbert JB; Kumar S; Gupta V; Cohen RE; Rubner MF; Mitragotri S
    J Control Release; 2015 Feb; 199():29-36. PubMed ID: 25481443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory and protective effects of MT-031, a novel multitarget MAO-A and AChE/BuChE inhibitor in scopolamine mouse model and inflammatory cells.
    Liu W; Rabinovich A; Nash Y; Frenkel D; Wang Y; Youdim MBH; Weinreb O
    Neuropharmacology; 2017 Feb; 113(Pt A):445-456. PubMed ID: 27984078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.